Insider Transactions in Q1 2023 at Vir Biotechnology, Inc. (VIR)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2023
|
Ann M. Hanly EVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,627
-2.24%
|
$57,794
$22.77 P/Share
|
|
Mar 27
2023
|
Sung Lee EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,500
+50.0%
|
-
|
|
Mar 08
2023
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
17,935
-1.33%
|
$394,570
$22.59 P/Share
|
|
Mar 03
2023
|
Johanna Friedl Naderer EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,482
-0.99%
|
$32,604
$22.82 P/Share
|
|
Mar 01
2023
|
Charles Elliott Sigal Director |
BUY
Open market or private purchase
|
Indirect |
2,500
+20.0%
|
$55,000
$22.73 P/Share
|
|
Feb 27
2023
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,320
-2.62%
|
$237,360
$23.28 P/Share
|
|
Feb 24
2023
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
15,119
-4.19%
|
$347,737
$23.15 P/Share
|
|
Feb 23
2023
|
Ann M. Hanly EVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,302
-1.93%
|
$57,550
$25.97 P/Share
|
|
Feb 23
2023
|
Howard Horn CFO |
SELL
Open market or private sale
|
Direct |
2,248
-0.97%
|
$56,200
$25.97 P/Share
|
|
Feb 23
2023
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,878
-1.43%
|
$71,950
$25.97 P/Share
|
|
Feb 23
2023
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
12,631
-6.44%
|
$315,775
$25.97 P/Share
|
|
Feb 23
2023
|
Steven J. Rice Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,795
-1.63%
|
$44,875
$25.97 P/Share
|
|
Feb 22
2023
|
Ann M. Hanly EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+23.88%
|
-
|
|
Feb 22
2023
|
Phillip Pang EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+22.97%
|
-
|
|
Feb 22
2023
|
Johanna Friedl Naderer EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+28.57%
|
-
|
|
Feb 22
2023
|
Steven J. Rice Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,000
+39.85%
|
-
|
|
Feb 21
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
74,477
-0.1%
|
$2,085,356
$28.01 P/Share
|
|
Feb 21
2023
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
17,856
-4.26%
|
$499,968
$28.41 P/Share
|
|
Feb 17
2023
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
9,894
-4.42%
|
$247,350
$25.29 P/Share
|
|
Feb 17
2023
|
Howard Horn CFO |
SELL
Open market or private sale
|
Direct |
2,424
-1.03%
|
$60,600
$25.29 P/Share
|
|
Feb 17
2023
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,802
-1.95%
|
$70,050
$25.29 P/Share
|
|
Feb 17
2023
|
Steven J. Rice Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,981
-5.05%
|
$49,525
$25.29 P/Share
|
|
Feb 15
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
38,964
-0.21%
|
$1,013,064
$26.75 P/Share
|
|
Feb 14
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
38,907
-0.21%
|
$1,011,582
$26.81 P/Share
|
|
Feb 13
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
79,050
-0.21%
|
$1,976,250
$25.96 P/Share
|
|
Feb 10
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
97,221
-0.26%
|
$2,527,746
$26.05 P/Share
|
|
Feb 09
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
137,050
-0.24%
|
$3,563,300
$26.5 P/Share
|
|
Feb 08
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
81,914
-0.14%
|
$2,293,592
$28.21 P/Share
|
|
Feb 08
2023
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
17,915
-0.66%
|
$501,620
$28.68 P/Share
|
|
Feb 07
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
63,508
-0.17%
|
$1,841,732
$29.14 P/Share
|
|
Feb 06
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
45,249
-0.12%
|
$1,312,221
$29.97 P/Share
|
|
Feb 03
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
68,786
-0.18%
|
$2,063,580
$30.16 P/Share
|
|
Feb 02
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
86,801
-0.45%
|
$2,517,229
$29.7 P/Share
|
|
Feb 01
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
61,834
-0.16%
|
$1,731,352
$28.99 P/Share
|
|
Jan 31
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
73,883
-0.19%
|
$2,142,607
$29.19 P/Share
|
|
Jan 30
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
78,930
-0.2%
|
$2,288,970
$29.76 P/Share
|
|
Jan 24
2023
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-17.24%
|
$900,000
$30.0 P/Share
|
|
Jan 24
2023
|
Phillip Pang EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+7.81%
|
$90,000
$3.37 P/Share
|
|
Jan 23
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,512
-0.09%
|
$1,022,336
$28.13 P/Share
|
|
Jan 20
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
144,358
-0.37%
|
$3,897,666
$27.19 P/Share
|
|
Jan 19
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
69,839
-0.18%
|
$1,815,814
$26.27 P/Share
|
|
Jan 18
2023
|
George A Scangos Director |
BUY
Other acquisition or disposition
|
Indirect |
64,930
+26.52%
|
-
|
|
Jan 18
2023
|
George A Scangos Director |
SELL
Other acquisition or disposition
|
Indirect |
64,930
-1.8%
|
-
|
|
Jan 18
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
102,467
-0.52%
|
$2,664,142
$26.31 P/Share
|
|
Jan 17
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
88,372
-0.45%
|
$2,297,672
$26.24 P/Share
|
|
Jan 13
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
94,199
-0.47%
|
$2,449,174
$26.54 P/Share
|
|
Jan 12
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
117,479
-0.29%
|
$3,054,454
$26.27 P/Share
|
|
Jan 11
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
79,065
-0.2%
|
$2,055,690
$26.08 P/Share
|
|
Jan 10
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
70,575
-0.35%
|
$1,834,950
$26.41 P/Share
|
|
Jan 09
2023
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
17,915
-1.3%
|
$447,875
$25.83 P/Share
|